LIVN
LIVN
NASDAQ · Health Care

Livanova Plc

$76.42
-1.73 (-2.21%)
Financial Highlights (FY 2026)
Revenue
1.40B
Net Income
-245,388,644
Gross Margin
67.7%
Profit Margin
-17.5%
Rev Growth
+10.8%
D/E Ratio
0.31
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 56.7% 56.7%
Operating Margin 14.1% 12.7% 20.0% 18.3%
Profit Margin -17.5% -16.6% 16.6% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.40B 1.27B 866.49M 838.17M
Gross Profit 951.16M 858.84M 491.05M 475.01M
Operating Income 197.93M 160.85M 173.09M 153.62M
Net Income -245,388,644 -199,412,893 144.22M 131.68M
Gross Margin 67.7% 67.7% 56.7% 56.7%
Operating Margin 14.1% 12.7% 20.0% 18.3%
Profit Margin -17.5% -16.6% 16.6% 15.7%
Rev Growth +10.8% +10.8% +3.7% +6.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 528.47M 528.47M 1.67B 1.31B
Total Equity 1.68B 1.68B 2.65B 2.44B
D/E Ratio 0.31 0.31 0.63 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 226.89M 194.62M 227.62M 227.59M
Free Cash Flow 128.87M 109.61M